Tianjin Tianyao Pharmaceuticals Co Ltd
SSE:600488
Wall Street
Price Targets
Price Targets Summary
Tianjin Tianyao Pharmaceuticals Co Ltd
According to Wall Street analysts, the average 1-year price target for Tianjin Tianyao Pharmaceuticals Co Ltd is 5.6 CNY .
Price Targets
Revenue
Forecast
Revenue Estimate
Tianjin Tianyao Pharmaceuticals Co Ltd
For the last 8 years the compound annual growth rate for Tianjin Tianyao Pharmaceuticals Co Ltd's revenue is 13%. The projected CAGR for the next 6 years is -10%.
Net Income
Forecast
Net Income Estimate
Tianjin Tianyao Pharmaceuticals Co Ltd
For the last 8 years the compound annual growth rate for Tianjin Tianyao Pharmaceuticals Co Ltd's net income is 5%. The projected CAGR for the next 6 years is 1%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Tianjin Tianyao Pharmaceuticals Co Ltd's stock price target?
Price Target
5.6
CNY
According to Wall Street analysts, the average 1-year price target for Tianjin Tianyao Pharmaceuticals Co Ltd is 5.6 CNY .
What is Tianjin Tianyao Pharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
-10%
For the last 8 years the compound annual growth rate for Tianjin Tianyao Pharmaceuticals Co Ltd's revenue is 13%. The projected CAGR for the next 6 years is -10%.
What is Tianjin Tianyao Pharmaceuticals Co Ltd's Net Income forecast?
Projected CAGR
1%
For the last 8 years the compound annual growth rate for Tianjin Tianyao Pharmaceuticals Co Ltd's net income is 5%. The projected CAGR for the next 6 years is 1%.